Markets.com Logo

ADXS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0532$
  • Previous Close
    0.0532$
  • 52 Week Change
    0.76$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.02$ - 0.777$
  • Dividend Per Share
    --
  • Market cap
    2 257 K$
  • EPS
    0
  • Beta
    --
  • Volume
    --

About

ADXS.US was the stock ticker symbol for Advaxis, Inc., a biotechnology company focused on developing cancer immunotherapies. Advaxis was based in Princeton, New Jersey, and their primary technology platform was based on Listeria monocytogenes (Lm)-based antigen delivery. The company aimed to harness the power of the body's immune system to target and destroy cancer cells. However, Advaxis struggled financially and operationally. Trading of ADXS.US was ultimately suspended, and the company entered bankruptcy. The stock is no longer actively traded on major exchanges.
Tesla Stock (NASDAQ:TSLA) jumps 4.3%: Why are Tesla shares trading up?

Tesla Stock (NASDAQ:TSLA) jumps 4.3%: Why are Tesla shares trading up?

Ghko B|--
AVGO stock crashed 5.6% today: what’s happening with Broadcom Inc?

AVGO stock crashed 5.6% today: what’s happening with Broadcom Inc?

Ghko B|--
AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

Frances Wang|--
RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

Frances Wang|--
Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Frances Wang|--
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--

Factors

Clinical Trial Results: Positive data from Advaxis' clinical trials often leads to increased investor confidence and higher stock prices. Conversely, negative or inconclusive results can cause the price to fall.

Regulatory Approvals: FDA approvals for Advaxis' immunotherapy drugs are major catalysts that typically drive significant stock price increases. Rejections or delays can negatively impact the stock.

Partnerships and Collaborations: Strategic partnerships with larger pharmaceutical companies or research institutions can boost investor sentiment and increase the stock price due to validation and potential funding.

Financial Performance: Advaxis' cash position, burn rate, and ability to secure funding influence investor confidence. Concerns about financial stability can depress the stock price.

Market Sentiment: Overall market conditions and investor appetite for risk, particularly in the biotech sector, can affect ADXS.US. Positive market sentiment tends to lift the stock.

Competition: The competitive landscape in the immunotherapy space impacts investor perception of Advaxis' potential. Strong competition can pressure the stock price.

News and Media Coverage: News articles, analyst ratings, and social media discussions can influence investor behavior and affect the stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Best CFD Trading Platform for 2026: How to Choose CFD Trading Brokers?

Best CFD Trading Platform for 2026: How to Choose CFD Trading Brokers?

Ghko B|--
What does CFD mean in trading: How to start CFD Trading in 2026?

What does CFD mean in trading: How to start CFD Trading in 2026?

Ghko B|--
A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--